Positive EMA Feedback Boosts Momentum for Tharimmune’s Phase 2 Trial in Treating Debilitating Itch Condition in Primary Biliary Cholangitis Tharimmune...
New Manufacturing Facility, Growing Revenue, and Strategic Partnerships Pave the Way for Enovix's 2025 Market Entry Enovix Corporation (ENVX), a...
SaaS Pioneer Leverages AI and AR Technologies to Propel Revenue, Despite Market Challenges Perfect Corp. (PERF), a leading provider of...
Strategic Acquisitions and Agent Expansion Fuel Rapid Growth, with Forecasted Annual Revenue Run Rate of $100 Million by Year-End La...
GreenWaste to Lead Sustainability Efforts with Zero-Emission Fuel Cell Electric Vehicles Hyzon Motors (HYZN), a leading U.S.-based manufacturer of hydrogen...
Stoxpo: Immunocore has made strides with KIMMTRAK in treating uveal melanoma. What has contributed to this success? Bahija Jallal: KIMMTRAK...
In an unexpected and dramatic move, Bright Minds Biosciences (DRUG) saw its stock skyrocket by an astonishing 1,400% yesterday, despite...
State-of-the-art facility supports advanced cancer treatment applications, accelerating product distribution Perspective Therapeutics (CATX), a leading radiopharmaceutical company, has announced the...
Sentinel Cohort Launched as Oral Vaccine Advances Towards FDA and BARDA Support Vaxart Inc. (VXRT) has announced the initiation of...
Distribution Agreement with Sekorm Paves Way for B-TRAN Technology Expansion in World's Largest Semiconductor Market Ideal Power (IPWR), a leader...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?